MC
465.45
+2.5%↑
SANES
9.598
+4.29%↑
SAF
287.7
+2.42%↑
BBVA
18.415
+3.22%↑
BNP
83.36
+1.25%↑
MC
465.45
+2.5%↑
SANES
9.598
+4.29%↑
SAF
287.7
+2.42%↑
BBVA
18.415
+3.22%↑
BNP
83.36
+1.25%↑
MC
465.45
+2.5%↑
SANES
9.598
+4.29%↑
SAF
287.7
+2.42%↑
BBVA
18.415
+3.22%↑
BNP
83.36
+1.25%↑
MC
465.45
+2.5%↑
SANES
9.598
+4.29%↑
SAF
287.7
+2.42%↑
BBVA
18.415
+3.22%↑
BNP
83.36
+1.25%↑
MC
465.45
+2.5%↑
SANES
9.598
+4.29%↑
SAF
287.7
+2.42%↑
BBVA
18.415
+3.22%↑
BNP
83.36
+1.25%↑
24h
Atual
Mín
25.9
Máximo
26.5
Rendimento | 27M |
|---|---|
Vendas | 1.6B |
P/E Médio do Setor | 10.15 54.048 |
Rendimento de Dividendos | 1.85 |
Margem de lucro | 1.718 |
Funcionários | 5,350 |
EBITDA | 14B |
Rendimento de Dividendos Médio do Setor | 1.85% 4.84% |
|---|---|
Próximos Ganhos | 1 de abr. de 2026 |
Capitalização de Mercado | 619M |
|---|---|
Abertura anterior | 27.89 |
Fecho anterior | 26 |
By Trading Central
Confiança
Strong Bullish Evidence
30.5 / N/A Suporte e Resistência
O desempenho passado não é um indicador confiável de resultados futuros.
23 de mar. de 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Ler
23 de mar. de 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Ler
23 de mar. de 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Ler
23 de mar. de 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Ler
23 de mar. de 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Ler
23 de mar. de 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Ler
23 de mar. de 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Ler
23 de mar. de 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Ler
23 de mar. de 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Ler
23 de mar. de 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Ler
23 de mar. de 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Ler
23 de mar. de 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Ler
23 de mar. de 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Ler
23 de mar. de 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Ler
23 de mar. de 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Ler
23 de mar. de 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Ler
23 de mar. de 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Ler
23 de mar. de 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Ler
Variação de preço
By TipRanks
0 ratings
0
Comprar
0
Manter
0
Vender
Com base em 0 analistas que deram avaliações de ações para Synergie SA. - Dist nos últimos 3 meses.
By Trading Central
Curto Prazo
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Médio Prazo
Bullish Evidence
Recent bullish events outweigh bearish events.
Longo Prazo
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$